Total planned funding: $183,993,686
Allocations
Countries/Regions
India | $183,993,686 |
Organizational Types
Unknown | $103,165,899 |
NGO | $35,950,064 |
Own Agency | $24,181,426 |
University | $8,990,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,206,808 |
Host Country Government Agency | $1,201,000 |
FBO | $1,100,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $75,150,059 |
Prevention | $43,781,471 |
Care | $21,931,589 |
Management and Operations | $20,060,466 |
Testing | $10,210,071 |
Treatment | $8,432,238 |
Budget Codes
OHSS: Health Systems Strengthening | $45,795,500 |
HVSI: Strategic Information | $24,413,994 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,168,051 |
HVMS: Management and Operations | $20,060,466 |
HBHC: Care: Adult Care and Support | $15,005,311 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,824,319 |
HVCT: Testing: HIV Testing and Counseling | $10,210,071 |
HTXS: Treatment: Adult Treatment | $8,051,967 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,296,481 |
HLAB: Laboratory Infrastructure | $4,940,565 |
HKID: Care: Orphans and Vulnerable Children | $4,633,676 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,452,379 |
HVTB: Care: TB/HIV | $2,032,585 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $356,794 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$103,165,899
Countries/Regions
USG Aggregated Agencies:
$18,188,527
Countries/Regions
FHI 360:
$16,042,311
Countries/Regions
Voluntary Health Services:
$5,260,000
Countries/Regions
University of Washington:
$4,450,000
Countries/Regions